News
15d
Inquirer Opinion on MSNMpox impactsOver dinner with my family, I casually asked if they were aware of monkeypox or mpox. They responded in the affirmative and said that they heard it on the news but were not alarmed because they had a ...
6hon MSN
The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...
The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...
The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...
5don MSN
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...
Learning the best type of HIV prevention for those at highest risk can start with conversations about their options, writes ...
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results